All lobbying filings

Federal Health Counsel, LLC

Federal Health Counsel, LLC filed a Q4 report for Amgen, Inc. on January 26, 2026.

Lobbying for Amgen, Inc. · Pharmaceutical Company

As filed: FEDERAL HEALTH COUNSEL, LLC for AMGEN, INC.

All filings by Federal Health Counsel, LLC · Everything Amgen, Inc. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 26, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

District of Columbia

Official filing document

Lobbying activity 1

Medicare/Medicaid

Issues related to the implementation of the Medicare Drug Negotiations and the calculation of the Medicaid Rebate and Best Price. issues relating to MFN pricing and other price controls in drugs.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.